ConductScience.org, home

Trial · NCT02502903

Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders

NCT02502903, Phase 1, Completed, Bioverativ, a Sanofi company

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders. Trials, record NCT02502903. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02502903

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders
NCT number
NCT02502903
Status
Completed
Phases
Phase 1
Enrollment
122 participants, actual
Lead sponsor
Bioverativ, a Sanofi company
Conditions
Bullous Pemphigoid (BP), Cold Agglutinin Disease (CAD), Warm Autoimmune Hemolytic Anemia (WAIHA), End-stage Renal Disease (ESRD)
Interventions
BIV009, Placebo
First posted
2015-07-20
Last updated
2022-04-25
Other registries' IDs
eudract:2014-003881-26

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDrug-related Adverse Event profile of BIVV0096 weeksSerious and Non-Serious adverse events probably or possibly attributable to BIVV009
SecondaryPharmacokinetic profile of BIVV0096 weeksTmax, Cmax, Area under curve (AUC) and T1/2
SecondaryClassical pathway complement system activity6 weeksinhibition by BIVV009 of the complement system classical pathway measured by the WIESLAB® assay
SecondaryComplement System-Related biomarkers6 weekse.g. CH50
SecondaryCoagulation System-Related biomarkers6 weekse.g. Fibrin D-dimer
SecondaryDisease-Related Biomarkers6 weekse.g. Haptoglobin

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers5

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
27716293DERIVEDPubMed
28926521DERIVEDPubMed
28980446DERIVEDPubMed
30559259DERIVEDPubMed
38995690DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02502903

GET https://conductscience.org/api/trials/v1/NCT02502903/registered